Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis

Nano vaccines for T. gondii Ribosomal P2 Protein With Nanomaterials as a Promising DNA Vaccine Against Toxoplasmosis

Caused by Toxoplasma gondii, toxoplasmosis has aroused great threats to public health around the world. So far, no effective vaccine or drug is commercially available, and the demands for a safe and effective therapeutic strategy have become more and more urgent. In the current study, we constructed...

Full description

Bibliographic Details
Main Authors: ZhengQing Yu, Ke He, WanDi Cao, Muhammad Tahir Aleem, RuoFeng Yan, LiXin Xu, XiaoKai Song, XiangRui Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Immunology
Subjects:
Toxoplasma gondii
ribosomal P2 protein
PLGA
chitosan
immunoprotection
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.839489/full

Similar Items

Similar Items